Melissa Kim
HEALTHTECH AND LIFE SCIENCES
Melissa Kim has a passion for emerging technology in healthcare, building and advising startups.
She has a PhD in Microbiology from Columbia University PhD with 20 years in healthcare spanning both strategy & operations, and broad exposure across multiple disease areas and technology platforms (drugs, devices, digital health)
In Silicon Valley where she resides, Melissa founded & led 2 companies: an antiviral biotech startup and an advisory platform in next gen women's health. She led marketing & market development at digital health startups with successful exits (Propeller Health acquired by ResMed & Physera acquired by Omada Health).
At Gilead Sciences & Roche/Genentech she led commercial planning & advised both BD & R&D teams across disease areas. She was a sell side equity Research Analyst early in her career at JP Morgan & UBS covering small & mid cap US healthcare technology & life science tools.
Expertise
Healthcare VC, deep roots in health tech with a foundation in BioPharma
Location
Silicon Valley
Roles
CEO, Operating Partner, Strategic Advisor
Sectors
Emerging technology in Healthcare, Biotech, Pharma and Digital Health
Traits
Curious, Strategic, Results-Oriented
Healthcare Technology
20 Years in healthcare spanning both strategy and operations
Marketing and market development with two digital health startups with successful exits
Advised BD and R&D teams across disease areas